Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials (Q33371189)
scientific article
Language:
Current Data About Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials
(P31) (Q13442814)
(P248)
(P698) 16699448
(P813) Wednesday, July 26, 2017

(Q815382)

(P50) (Q37834876)
(P1932) Angela C Webster
(P1545) 1

(Q38591193)
(P1932) Jonathan C Craig
(P1545) 4

(P304) 1234-1248
(P248)
(P698) 16699448
(P813) Wednesday, July 26, 2017

(P407) (Q1860)

(P433) 9
(P248)
(P698) 16699448
(P813) Wednesday, July 26, 2017

(P478) 81
(P248)
(P698) 16699448
(P813) Wednesday, July 26, 2017

(P577) Monday, May 1, 2006
(P248)
(P698) 16699448
(P813) Wednesday, July 26, 2017

(P921) (Q815382)

(Q1455316)
(P887)

(Q1504425)
(P887)

(Q32089)
(P887)

(P1433) (Q15730500)
(P248)
(P698) 16699448
(P813) Wednesday, July 26, 2017

(P1476) "Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials" (language: en)
(P248)
(P698) 16699448
(P813) Wednesday, July 26, 2017

(P2093) Vincent W S Lee
(P1545) 2
(P248)
(P698) 16699448
(P813) Wednesday, July 26, 2017

Jeremy R Chapman
(P1545) 3
(P248)
(P698) 16699448
(P813) Wednesday, July 26, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article

External Links
(P356) 10.1097/01.TP.0000219703.39149.85
(P698) 16699448